Last reviewed · How we verify
NCT04988724
Impact of Physical Exercise at a Hospital
NA trial testing Exercise training in Pain in 700 participants. Currently enrolling.
18 December 2023
Quick facts
| Lead sponsor | Nordsjaellands Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 700 |
| Start date | 16 April 2022 |
| Primary completion | 18 December 2023 |
| Estimated completion | 31 December 2026 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- Exercise training
Conditions studied
- Pain — all drugs for Pain →
- Quality of Life — all drugs for Quality of Life →
- Health Behavior — all drugs for Health Behavior →
Sponsor
Nordsjaellands Hospital
Who can join
18 and older, any sex, with Pain or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aims and Hypotheses Aims * to investigate associations between an intelligent exercise training intervention and clinical health parameters, well-being, sick leave and productivity at Nordsjællands Hospital (NOH) * to generate data and experiences to a larger cluster randomized trial with more included departments at NOH * to analyze how the intervention could be successfully implemented in the organization to ensure long-term effects Outcomes * Aerobic capacity (Åstrand's ergometer test) * Blood pressure and heart rate * Physical activity (steps measured by tracker) * Self-reported health (questionnaire EQ-5D) * Self-reported physical activity (questionnaire IPAQ) * Well-being (questions from the Danish Health and Morbidity Survey) * Musculoskeletal pain and use of anti-pain medications (Numeric Rating Scale) * Monetized value of productivity loss * Productivity using an employer´s perspective (scale 1-10) * Sick leave (days in short term (≤14 days) and long term (\>14 days), data will be delivered by The Department of HR) * Muscle strength in knee extension (dynamometer) Intervention The concept of intelligent training at the worksite is an individualized exercise training where the exercises are: 1) balanced to the physiological capacity of the employees relative to their occupational exposure, 2) tailored to the individual capacities and disorders to improve employees' health, 3) motivating by offering evidence based and enjoyable programs implemented with care, and 4) cost-effective for the company. The intervention period is 20 weeks of intelligent exercise training. Every week, several exercise sessions will be offered to the participants in the intervention group during the working hours. The exercise sessions will be of 30 min durations twice a week and include aerobic exercise with high intensity (≥16 on the Borg scale, rate of perceived exhaustion), resistance training and/or functional training. In addition, there will be a number of intelligent exercise sessions of 30 min durations before and after the most common working hours with a primary focus on aerobic exercise. The exercise sessions will be supervised by exercise experts (education in sport or physiotherapy). The intelligent exercise interventions will be adjusted to the individual participant's physical capacity and limitations; thus, as one participant may perform aerobic exercise, another person may perform resistance training.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Feasibility and Effects of Exercise During Working Hours in Acute Hospital Staff - A Non-Randomized Controlled Trial.
Nielsen SG, Pedersen M, Toftager-Oster JU, Saervoll CA, et al · · 2026 · cited 1× · PMID 39966325 · DOI 10.1007/s10926-025-10275-6 -
Feasibility of exercise during working hours in acute hospital staff
Nielsen SG, Pedersen M, Toftager-Oster JU, Saervoll CA, et al · · 2024 · DOI 10.21203/rs.3.rs-5317156/v1
Verify or expand the search:
- PubMed search for NCT04988724
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise training
Trials testing the same drug.
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
- NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
- NCT07300332 — Exercise Training and Vitamin D Metabolism · NA · recruiting
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Nordsjaellands Hospital trials
Trials by the same sponsor.
- NCT07167498 — Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil · not yet recruiting
- NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
- NCT06689280 — Physical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomised-Control · NA · not yet recruiting
- NCT06564857 — Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation · Phase 4 · recruiting
- NCT07132723 — Associations Between Time to Reduction and Complications in Patients With Dislocated Total Hip Arthroplasty · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04988724 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nordsjaellands Hospital
- Last refreshed: 5 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04988724.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing